rs183378773
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000373004.5(SRPX2):c.1289G>A(p.Arg430His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,209,534 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R430C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000373004.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX2 | NM_014467.3 | c.1289G>A | p.Arg430His | missense_variant | 11/11 | ENST00000373004.5 | NP_055282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.1289G>A | p.Arg430His | missense_variant | 11/11 | 1 | NM_014467.3 | ENSP00000362095 | P1 | |
SRPX2 | ENST00000640282.1 | c.*24G>A | 3_prime_UTR_variant | 3/3 | 5 | ENSP00000491188 | ||||
SRPX2 | ENST00000638920.1 | n.1292G>A | non_coding_transcript_exon_variant | 10/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111335Hom.: 0 Cov.: 23 AF XY: 0.0000895 AC XY: 3AN XY: 33529
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183418Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67862
GnomAD4 exome AF: 0.0000382 AC: 42AN: 1098145Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 12AN XY: 363499
GnomAD4 genome AF: 0.0000359 AC: 4AN: 111389Hom.: 0 Cov.: 23 AF XY: 0.0000595 AC XY: 2AN XY: 33593
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.1289G>A (p.R430H) alteration is located in exon 11 (coding exon 10) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 1289, causing the arginine (R) at amino acid position 430 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2017 | This sequence change replaces arginine with histidine at codon 430 of the SRPX2 protein (p.Arg430His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs183378773, ExAC 0.03%). This variant has not been reported in the literature in individuals with an SRPX2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, this variant has uncertain impact on SRPX2 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at